Botulinum Toxin Research, Revance deal

Botulinum Toxin Research granted Revance IP related to botulinum toxin. Botulinum Toxin Research also granted Revance the right of first negotiation and right of first refusal for other IP owned by Botulinum Toxin Research. ...